Uncoupled Ressearch Fellowship [ 2009 - 2013 ]

Related Publications

• Associated with A novel fluorometric assay for aldo-keto reductase 1C3 predicts metabolic activation of the nitrogen mustard prodrug PR-104A in human leukaemia cells
  handle : 1959.4/unsworks_12958
  
• Associated with A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia
  handle : 1959.4/unsworks_12927
  
• Associated with Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia
  handle : 1959.4/unsworks_12930
  
• Associated with Combined Targeting of JAK2 and Bcl-2/Bcl-xL to Cure Mutant JAK2-Driven Malignancies and Overcome Acquired Resistance to JAK2 Inhibitors
  handle : 1959.4/unsworks_12921
  
• Associated with Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemia
  handle : 2440/94901
  
Show all 22 related publications
• Associated with Disparate in vivo efficacy of FTY720 in xenograft models of philadelphia positive and negative B-lineage acute lymphoblastic leukemia
  URI : researchoutputs.unisa.edu.au/1959.8/155530
  
• Associated with Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex
  handle : 1959.4/unsworks_12941
  
• Associated with FBXW7 regulates glucocorticoid response in T-cell acute lymphoblastic leukaemia by targeting the glucocorticoid receptor for degradation
  handle : 1959.4/unsworks_12947
  
• Associated with Histone Deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1
  handle : 1959.4/unsworks_12908
  
• Associated with Initial Testing (Stage 1) of Temozolomide by the Pediatric Preclinical Testing Program
  handle : 1959.4/unsworks_12953
  
• Associated with Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the Pediatric Preclinical Testing Program
  handle : 1959.4/unsworks_12951
  
• Associated with Initial testing (stage 1) of ganetespib, an Hsp90 inhibitor, by the Pediatric Preclinical Testing Program
  handle : 1959.4/unsworks_12949
  
• Associated with Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program
  handle : 1959.4/unsworks_12948
  
• Associated with Initial testing (stage 1) of the notch inhibitor PF-03084014, by the pediatric preclinical testing program
  handle : 1959.4/unsworks_12928
  
• Associated with Initial testing (stage 1) of the phosphatidylinositol 3’ kinase inhibitor, SAR245408 (XL147) by the Pediatric Preclinical Testing Program
  handle : 1959.4/unsworks_12952
  
• Associated with Initial testing (stage 1) of the polo-like kinase inhibitor volasertib (BI 6727), by the Pediatric Preclinical Testing Program
  handle : 1959.4/unsworks_12950
  
• Associated with Stability of gene expression and epigenetic profiles highlights the utility of patient-derived paediatric acute lymphoblastic leukaemia xenografts for investigating molecular mechanisms of drug resistance
  handle : 1959.4/unsworks_12922
  
• Associated with Targeting acute myeloid leukemia by dual inhibition of P13K signalling and Cdk9-mediated Mcl-1 transcription
  handle : 1959.4/unsworks_12923
  
• Associated with Targeting connective tissue growth factor (CTGF) in acute lymphoblastic leukemia preclinical models: Anti-CTGF monoclonal antibody attenuates leukemia growth
  handle : 1959.4/unsworks_12926
  
• Associated with Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC
  handle : 1959.4/unsworks_12924
  
• Associated with The anti-CD19 antibody-drug conjugate SAR3419 prevents hematolymphoid relapse post induction therapy in preclinical models of pediatric acute lymphoblastic leukemia
  handle : 1959.4/unsworks_12957
  
• Associated with Tumor protein 53-induced nuclear protein 1 enhances p53 function and represses tumorigenesis
  handle : 1959.4/unsworks_12920
  
Show less related publications